TOOLE JOHN Jofficer: SVP, Clinical Researchofficer: SVP, Clinical Research
Common Stock
10,000
$7.08
$70,780
Sale
TOOLE JOHN Jofficer: SVP, Clinical Researchofficer: SVP, Clinical Research
Common Stock
33,260
$36
$1,197,393
Sale
BERG PAULdirectordirector
Common Stock
8,000
$4.78
$38,248
Option
BERG PAULdirectordirector
Non-qualified Stock Option (right to buy)
8,000
$4.78
$38,248
Option
TOOLE JOHN Jofficer: SVP, Clinical Researchofficer: SVP, Clinical Research
Non-Qualified Stock Option (right to buy)
10,000
$7.08
$70,780
Sale
LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Common Stock
61,432
$37.5
$2,303,946
Option
MARTIN JOHN Cdirectordirector
Common Stock
120,000
$4.09
$491,280
Sale
MARTIN JOHN Cdirectordirector
Common Stock
120,000
$37.37
$4,484,760
Option
MARTIN JOHN Cdirectordirector
Non-Qualified Stock Option (right to buy)
120,000
$4.09
$491,280
Option
LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Non-Qualified Stock Option (right to buy)
61,432
$4.97
$305,256
Option
LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Common Stock
61,432
$4.97
$305,256
Sale
TOOLE JOHN Jofficer: SVP, Clinical Researchofficer: SVP, Clinical Research
Common Stock
9,400
$35.33
$332,102
Sale
MOORE GORDON EARLEdirectordirector
Common Stock
770
$34.92
$26,888
Option
BISCHOFBERGER NORBERT Wofficer: EVP, R&D and CSOofficer: EVP, R&D and CSO
Non-Qualified Stock Option (right to buy)
180,000
$7.3
$1,313,460
Option
BISCHOFBERGER NORBERT Wofficer: EVP, R&D and CSOofficer: EVP, R&D and CSO
Common Stock
180,000
$7.3
$1,313,460
Sale
BISCHOFBERGER NORBERT Wofficer: EVP, R&D and CSOofficer: EVP, R&D and CSO
Common Stock
180,000
$35.21
$6,337,620
Option
MILLIGAN JOHN Fdirector, officer: President and CEOdirector, officer: President an..
Common Stock
22,000
$7.41
$162,932
Option
MILLIGAN JOHN Fdirector, officer: President and CEOdirector, officer: President an..
Non-Qualified Stock Option (right to buy)
22,000
$7.41
$162,932
Sale
MILLIGAN JOHN Fdirector, officer: President and CEOdirector, officer: President an..
Common Stock
22,000
$34.51
$759,110
Sale
BERG PAULdirectordirector
Common Stock
8,000
$4.78
$38,248
Option
BERG PAULdirectordirector
Non-qualified Stock Option (right to buy)
8,000
$4.78
$38,248
Sale
BERG PAULdirectordirector
Common Stock
8,000
$4.78
$38,248
Option
BERG PAULdirectordirector
Non-qualified Stock Option (right to buy)
8,000
$4.78
$38,248
Option
TOOLE JOHN Jofficer: SVP, Clinical Researchofficer: SVP, Clinical Research
Common Stock
8,650
$9.26
$80,099
Sale
TOOLE JOHN Jofficer: SVP, Clinical Researchofficer: SVP, Clinical Research
Common Stock
10,000
$68.63
$686,280
Option
TOOLE JOHN Jofficer: SVP, Clinical Researchofficer: SVP, Clinical Research
Non-qualified Stock Option (right to buy)
80
$6.59
$528
Option
TOOLE JOHN Jofficer: SVP, Clinical Researchofficer: SVP, Clinical Research
Incentive Stock Option (right to buy)
422
$6.59
$2,783
Sale
LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Common Stock
38,088
$64.67
$2,463,037
Option
LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Non-Qualified Stock Option (right to buy)
3,968
$6.59
$26,165
Option
LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Common Stock
3,968
$6.59
$26,165
Option
LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Common Stock
30,032
$6.59
$198,031
Option
LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Non-Qualified Stock Option (right to buy)
30,032
$6.59
$198,031
Sale
LEE WILLIAM Aofficer: SVP, Researchofficer: SVP, Research
Common Stock
30,032
$64.7
$1,942,980
Option
BISCHOFBERGER NORBERT Wofficer: EVP, R&D and CSOofficer: EVP, R&D and CSO
Common Stock
65,000
$10.56
$686,595
Sale
BISCHOFBERGER NORBERT Wofficer: EVP, R&D and CSOofficer: EVP, R&D and CSO
Common Stock
60,000
$45.98
$2,758,620
Option
BERG PAULdirectordirector
Non-qualified Stock Option (right to buy)
4,000
$9.56
$38,252
Option
BISCHOFBERGER NORBERT Wofficer: EVP, R&D and CSOofficer: EVP, R&D and CSO
Non Qualified Stock Option (right to buy)
65,000
$10.56
$686,595
Sale
BERG PAULdirectordirector
Common Stock
4,000
$9.56
$38,252
Option
MILLIGAN JOHN Fdirector, officer: President and CEOdirector, officer: President an..
Common Stock
8,000
$38.83
$310,624
Option
MARTIN JOHN Cdirectordirector
Non-Qualified Stock Option (right to buy)
60,000
$54.28
$3,256,800
Sale
MARTIN JOHN Cdirectordirector
Common Stock
10,000
$8.19
$81,880
Option
MILLIGAN JOHN Fdirector, officer: President and CEOdirector, officer: President an..
Non-Qualified Stock Option (right to buy)
7,780
$63.5
$494,030
Option
MILLIGAN JOHN Fdirector, officer: President and CEOdirector, officer: President an..
Non-Qualified Stock Optin (right to buy)
220
$14.16
$3,114
Option
MARTIN JOHN Cdirectordirector
Common Stock
45,000
$52.38
$2,357,190
Sale
MILLIGAN JOHN Fdirector, officer: President and CEOdirector, officer: President an..
Common Stock
220
$14.16
$3,114
Option
BERG PAULdirectordirector
Non-qualified Stock Option (right to buy)
4,000
$9.56
$38,252
Sale
BERG PAULdirectordirector
Common Stock
4,000
$9.56
$38,252
Sale
BERG PAULdirectordirector
Common Stock
4,000
$9.56
$38,252
Option
BERG PAULdirectordirector
Non-qualified Stock Option (right to buy)
4,000
$9.56
$38,252
Sale
BERG PAULdirectordirector
Common Stock
4,000
$9.56
$38,252
Showing 2900 to 2950 of 3053 results.
Insider trading
Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.
Who is insider?
Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.